CRISPR/Cas System Principles and the Differences Between Cas9 and Cas12a

CRISPR/Cas System Principles and the Differences Between Cas9 and Cas12a

01
Introduction to the CRISPR/Cas System

The CRISPR/Cas system is an adaptive immune system used by bacteria and archaea to defend themselves against foreign genetic material. The functionality of this system is divided into three distinct stages:

Stage 1: Adaptation
Bacteria identify PAM (Protospacer Adjacent Motif) sites within the invading nucleic acids via specific Cas proteins. The protospacer sequence is then integrated into the bacterium's own CRISPR array.

Stage 2: Expression and Maturation
The CRISPR array is transcribed into pre-crRNA (precursor RNA), which is enzymatically processed into mature crRNA. This crRNA then binds with Cas proteins to form a functional effector complex.

Stage 3: Interference
The crRNA guides the complex to recognize the PAM target on the invading nucleic acid, triggering the endonuclease activity of the Cas protein to cleave the target DNA sequence.

Introduction to the CRISPR/Cas System

02
Classification of CRISPR/Cas Systems

CRISPR/Cas systems are categorized into two classes and six types:

Class 1 includes Types I, III, and IV. These systems function through multi-Cas protein complexes and account for 90% of identified CRISPR/Cas loci.

Class 2 includes Types II (Cas9), V (Cas12), and VI (Cas13). These systems function via a single effector Cas protein and account for 10% of identified CRISPR/Cas loci, making them ideal tools for gene editing and in vitro diagnostics.

CRISPR/Cas systems are categorized into two classes and six types

03
Differences Between Cas12a and Cas9

1. crRNA

In the case of Cas9, upon the invasion of exogenous nucleic acids, the bacterium transcribes tracrRNA while the Cas9 protein is simultaneously transcribed and translated. Cas1, Cas2, and Csn2 will attach to the Cas9 protein. Subsequently, the CRISPR array, regulated by the leader sequence, is transcribed into pre-crRNA.

The pre-crRNA and tracrRNA form a double-stranded RNA through complementary base pairing and assemble with the Cas9 protein into a complex. Finally, based on the type of invading nucleic acid, the corresponding spacer sequence is selected, and RNase III is utilized to cleave irrelevant sequences, resulting in the formation of a mature sgRNA (single guide RNA).

crRNA

Because Cas12a possesses intrinsic ribonuclease activity, once pre-crRNA is transcribed, Cas12a can directly process pre-crRNA into its mature form without the involvement of tracrRNA or RNase III. In addition, Cas12a exhibits RNA-guided DNase activity, enabling it to cleave the target DNA.

cas12a

EDITGENE provides crRNA design and synthesis services. With its proprietary crRNA design strategy, the detection limit can be improved to the attomole level, while the assay time is reduced to as short as ten minutes. This approach significantly enhances the sensitivity and cleavage activity of CRISPR-based detection.

2. PAM Sites and Domains

For Cas9, the target DNA’s PAM sequence is 5’-NGG-3’, located downstream of the spacer region on the non-target strand. Cas9’s nuclease consists of an HNH nuclease domain and a RuvC-like nuclease domain, both of which participate in DNA cleavage. The HNH domain cleaves the DNA strand complementary to the crRNA, while the RuvC-like domain cuts the non-complementary strand. The cleavage site lies between the third and fourth nucleotides upstream of the PAM within the original spacer sequence, producing a blunt-ended double-strand break (DSB).

PAM Sites and Domains
Cas12a recognizes T-rich PAM sequences, such as 5’-TTTN-3’ for LbCas12a and 5’-TTN-3’ for FnCas12a, located upstream of the spacer region on the non-target strand.

Cas12a adopts a bilobed structure composed of a REC lobe and a Nuc lobe, with nuclease activity localized in the Nuc lobe. The Nuc lobe contains the RuvC domain, the PI domain, and the WED domain. The RNase site responsible for processing its own crRNA resides in the WED domain, whereas the DNase site for DNA cleavage is located at the interface between the Nuc and RuvC domains. The RuvC domain contains the catalytic center, enabling precise recognition of the target sequence and accurate DNA cleavage under Mg²⁺ catalysis, generating staggered DSBs with sticky ends.

PAM Sites and Domains

3. Mechanism of Action

When Cas9 cleaves DNA, it generates a double-strand break (DSB), triggering the cell’s DNA damage repair machinery.

Two major repair pathways exist in cells. One is non-homologous end joining (NHEJ), which can introduce small insertions, deletions, or substitutions. If the number of inserted or deleted bases is not a multiple of three, the resulting amino acid sequence produced during translation will differ completely from the original, effectively achieving gene knockout (KO).

The other pathway is homology-directed repair (HDR), which restores the DNA sequence to its pre-break state. However, NHEJ is generally the dominant repair mechanism in cells. Even when DNA is repaired via HDR, the site can still be recognized by sgRNA and subjected to repeated cleavage.

Mechanism of Action

Figure 6. DNA repair pathways after Cas9 cleavage

Cas12a’s RuvC domain contains several specialized structural elements:
REC Linker (Linker): a looped peptide connecting the REC1 and REC2 domains.
Lid: regulates the closure of Cas12a’s catalytic pocket.
Finger: a helical, finger-like structure within REC1.

Before crRNA hybridizes with the target DNA, the Lid remains closed, and the Linker and Finger are inactive. Upon crRNA–DNA hybridization, the Lid opens, making the Cas12a catalytic pocket accessible. After Cas12a cleaves the double-stranded DNA, the Lid undergoes a conformational change to form an α-helix, interacting with the hybridized crRNA.

The Linker and Finger move the REC domain away from the RuvC domain. At this point, the distal portion of the dsDNA substrate dissociates from the complex, exposing the catalytic site, which can then indiscriminately cleave nearby single-stranded DNA—a phenomenon called trans-cleavage.

This non-specific cleavage activity can be harnessed in detection methods: by combining it with probes, researchers can develop CRISPR-based assays that are simpler, faster, and more precise for in vitro detection.

Mechanism of Action

04
Summary
Feature Cas9 Cas12a
Discovery year 2012 2015
Cas family type Type II Type V
Protein size 1000-1600 amino acids ~1300 amino acids
gRNA crRNA and tracrRNA crRNA
Pre-crRNA processing Requires host RNase III and tracrRNA Processed by intrinsic RNase activity
PAM sequence G-rich PAM T-rich PAM
Nuclease domains HNH and RuvC RuvC–Nuc
Cleavage pattern Blunt ends (upstream of PAM) Sticky ends (downstream of PAM)
Mechanism Relies on cellular DNA repair after cleavage Relies on Cas12a trans-cleavage activity

Enzyme Activity Comparison Chart

LbCas12a Activity Comparison Test
LwaCas13a Activity Comparison Test
LbCas12a Activity Comparison Test LwaCas13a Activity Comparison Test

EDITGENE focuses on CRISPR technology, offering a comprehensive range of high-quality gene editing services and in vitro diagnostic products, including CRISPR library screening , cellular gene editing , and CRISPR-based detection . We are committed to providing the most efficient technical support for research in CRISPR-related studies, gene function analysis, in vitro diagnostics, and therapeutic applications.

Follow us on social media

           

Contact us

+ 833-226-3234 (USA Toll-free)

+1-224-345-1927 (USA)

info@editxor.com



Leave a Reply

Your email address will not be published.Required Fields are marked

Recent Promotions

Recent Post

Contact Us
*
*
*
*
How did you hear about us: